Robinhood, Applovin jump as S&P 500 reshuffle boosts index entrants
LivaNova PLC (NASDAQ:LIVN) announced Wednesday the appointment of Donald Zurbay to its board of directors and as a member of the board’s Audit and Compliance Committee. His term begins Thursday.
According to a press release statement included in an SEC filing, Mr. Zurbay brings more than two decades of leadership experience in the healthcare sector. He most recently served as President, Chief Executive Officer, and board member of Patterson Companies, Inc., a distributor of dental and animal health products and services, from October 2022 until May 2025. Prior to that, he was Chief Financial Officer of Patterson Companies from June 2018 to October 2022.
Mr. Zurbay also held several leadership roles over 13 years at St. Jude Medical, Inc., including Vice President and Corporate Controller from March 2004 to August 2012, and Chief Financial Officer from August 2012 to February 2017.
LivaNova stated that Mr. Zurbay will be compensated in line with the company’s Remuneration Policy for non-executive directors. He will receive a prorated annual board retainer fee of $70,000, an Audit and Compliance Committee annual member fee of $15,000, and an annual, service-based restricted stock award with a fair market value of $185,000, prorated for his service until the 2026 Annual General Meeting.
The company reported that there are no arrangements or understandings with any other person regarding Mr. Zurbay’s appointment. LivaNova also confirmed that Mr. Zurbay has not participated in any transactions with the company since January 1, 2024, that would require disclosure under Item 404(a) of Regulation S-K.
LivaNova PLC , based in London, is listed on the NASDAQ Global Market under the ticker LIVN. The information in this article is based on a press release statement filed with the Securities and Exchange Commission.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.